Real-World Usage and Outcomes of Different Siltuximab Dosing Frequency in Idiopathic Multicentric Castleman Disease

Yoshito Nishimura1, Maria Santiago Estevez1, Hakeem Asad1

  • 1Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

Abstract

No abstract available in PubMed .